Metraipolis › archive › dc_740c8d016167

Efficacy of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Moderate-to-Severe COPD Exacerbations Among Patients with Type 2… — Europe PMC PMID:41011208

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41011208
DOI
10.3390/ph18091337
License (as archived)
solo-consultazione
Archived
2026-11-10T02:29:50.079Z
SHA-256 of the archived text
4f52db80d8dbd0b53a1f1c06f443d6b0f131fa668fffd43a431be679507e640b
Stable URL of this page
https://metraipolis.com/documento/dc_740c8d016167

How to cite

Efficacy of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Moderate-to-Severe COPD Exacerbations Among Patients with Type 2… — Europe PMC PMID:41011208 — Europe PMC (en), https://europepmc.org/article/MED/41011208 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_740c8d016167 (Metraipolis archive dc_740c8d016167, sha256 4f52db80d8dbd0b53a1f1c06f443d6b0f131fa668fffd43a431be679507e640b)
BibTeX
@misc{dc740c8d016167,
  title = {Efficacy of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Moderate-to-Severe COPD Exacerbations Among Patients with Type 2… — Europe PMC PMID:41011208},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41011208},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_740c8d016167; sha256 4f52db80d8dbd0b53a1f1c06f443d6b0f131fa668fffd43a431be679507e640b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011208. Agents can read the archived copy with the MCP tool read_document.